• Release of Enhanced CME Globex Credit Control Tools - Effective July 01, 2024

      • To
      • Clearing Member Firms; Chief Financial Officers; Back Office Managers
      • From
      • CME Clearing
      • #
      • 24-178
      • Notice Date
      • 21 June 2024
      • Effective Date
      • 01 July 2024

    • In order to enhance the risk management tools available to Clearing Members utilizing CME Globex®, CME Group (on behalf of CME/CBOT/NYMEX/COMEX) is rolling out enhanced CME Globex Credit Control functionality, commonly referred to as “Enhanced GC2”. CME Globex Credit Controls (GC2) is a front-end application that provides pre-execution risk controls that enable Clearing Member or Partner Exchange Clearing Member risk administrators to set exposure limits for order and trade activity transacted on CME Globex and cleared by CME Clearing.

      Effective July 1st, 2024, CME will make Enhanced GC2 available on a voluntary basis while still retaining the option for Clearing Members to continue using the Current GC2 functionality.

      Effective, July 29th, 2024, CME will switch all Clearing Members to the Enhanced GC2 functionality on a mandatory basis.

      Click here for the full text of the advisory

      24-178

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2025 CME Group Inc. All rights reserved.